![Dmitri Bobilev](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dmitri Bobilev
Direttore Tecnico/Scientifico/R&S presso
FUSN PHAR
Profilo
Dmitri Bobilev is currently the Chief Medical Officer at Fusion Pharmaceuticals, Inc. Prior to his current position, he worked as the Head of Clinical Development and Vice President at Vedanta Biosciences, Inc. from 2018 to 2020.
He also held the position of Vice President and Head of Clinical Development at Checkmate Pharmaceuticals, Inc. Dr. Bobilev earned a doctorate degree from Omsk State Medical Academy.
Posizioni attive di Dmitri Bobilev
| Società | Posizione | Inizio |
|---|---|---|
| FUSN PHAR | Direttore Tecnico/Scientifico/R&S | 07/11/2022 |
Precedenti posizioni note di Dmitri Bobilev
| Società | Posizione | Fine |
|---|---|---|
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Corporate Officer/Principal | 01/08/2020 |
| CHECKMATE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di Dmitri Bobilev
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
31
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Omsk State Medical Academy
 Omsk State Medical Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
